CDIO vs WRBY: stock comparison

Cardio Diagnostics Holdings Inc. Common stock

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, including concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.

Open CDIO dashboard ↗

Warby Parker Inc.

Warby Parker Inc. provides eyewear products in the United States and Canada. The company offers eyeglasses, sunglasses, single-vision lenses, progressive lenses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, travel cases, lenses cloth, anti-fog lens spray, and sun clip-ons through its retail stores, website, and mobile apps. In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.

Open WRBY dashboard ↗

CDIO vs WRBY

Compare the businesses

Cardio Diagnostics Holdings Inc. Common stock

Warby Parker Inc.

Sign in to keep comparing stocks